ArticleBMC pulmonary medicine2026
Therapeutic consequences of a diagnostic broncho-alveolar lavage in patients in the Intensive Care Unit due to COVID-19: a retrospective cohort study.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhen patients with coronavirus disease 2019 (COVID-19) on the Intensive Care Unit (ICU) were not improving or clinically deteriorated, bronchoscopy with broncho-alveolar lavage (BAL) was performed to rule out potentially treatable bacterial, viral and fungal superinfections. The purpose of this study was to investigate the therapeutic consequences of a diagnostic BAL in ICU patients with COVID-19.
methodsWe performed a retrospective analysis in a cohort of patients with COVID-19 on the ICU of the St. Antonius Hospital Nieuwegein in the Netherlands. We compared the administration of antibiotics, antifungal therapy and prednisolone on the day of the BAL and three days later. We hypothesized that a diagnostic BAL did not result in significant changes in therapeutic management.
resultsIn 73 ICU-patients with COVID-19 who underwent a BAL, the results led to changes in medication prescription in 62% (p < 0.01) of patients. In these patients, the antibiotic management changed in 36% (p < 0.01), the antifungal management in 21% (p < 0.01) and the prednisolone management in 34% (p < 0.01) of the patients.
conclusionsIn ICU-patients who did not improve and therefore underwent a BAL, there was a significant change in antibiotics, antifungal or prednisolone prescriptions in 62% of the patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.